Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism

COVID-19 is caused by Severe Acute Respiratory Syndrome Coronavirus-2, which has infected over thirty eight million individuals worldwide. Emerging evidence indicates that COVID-19 patients are at a high risk of developing coagulopathy and thrombosis, conditions that elevate levels of D-dimer. It is...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Farha, Mohamed, Al-Sabah, Salman, Hammad, Maha M., Hebbar, Prashantha, Channanath, Arshad Mohamed, John, Sumi Elsa, Taher, Ibrahim, Almaeen, Abdulrahman, Ghazy, Amany, Mohammad, Anwar, Abubaker, Jehad, Arefanian, Hossein, Al-Mulla, Fahd, Thanaraj, Thangavel Alphonse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756688/
https://www.ncbi.nlm.nih.gov/pubmed/33362545
http://dx.doi.org/10.3389/fphar.2020.587451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756688/
https://www.ncbi.nlm.nih.gov/pubmed/33362545
http://dx.doi.org/10.3389/fphar.2020.587451

Ejemplares similares